Navigation Links
New Study Finds Pharmacists and Nurses are the Most Effective Health Care 'Voices' in Promoting Medication Adherence
Date:12/22/2010

WOONSOCKET, R.I., Dec. 22, 2010 /PRNewswire/ -- A new study looking at in-person, electronic, telephonic, fax and mail communications that counsel patients to stay on their medications concludes that pharmacists at a retail store are the most influential health care "voice" in getting patients to take medicine as prescribed.

(Logo: http://photos.prnewswire.com/prnh/20090226/NE75914LOGO)

The research, based on a review of more than 40 years of studies published in medical journals, showed that nurses talking with patients as they are discharged from a hospital are the second most influential voice encouraging patients to stay on their medicines. Both in-store pharmacists and hospital-based nurses are more effective than pharmacists communicating to a patient via the telephone or doctors instructing patients regarding prescriptions, the researchers said.

These findings are contained in two separate reviews of medical journal studies sponsored by CVS Caremark and carried out by a team of researchers from Harvard University, Brigham and Women's Hospital and CVS Caremark. This week the American Journal of Managed Care (AJMC) published a review that focused on communications between pharmacists and nurses with their patients. The AJMC study builds upon a review by the same researchers that focused on doctor and patient communications and was published last May in the Journal of General Internal Medicine.

"There have been many studies on the subject of boosting adherence. We decided it was important to review the total body of work to determine which communication channel had the greatest impact," said William Shrank, MD, MSHS, of Brigham and Women's Hospital and Harvard, and a lead author of the studies. Shrank said the researchers combed through more than 6,500 medical journal articles published between 1966 and December 31, 2008, before reviewing 168 articles in full.  

The study found that programs using
'/>"/>

SOURCE CVS Caremark
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Frost & Sullivan Market Study Gives Thumbs Up for Pepex™ Trio™ One-Click™ Blood Glucose Meter
2. Regeneron and Bayer Report Positive Results for VEGF Trap-Eye in Phase 3 Study in Central Retinal Vein Occlusion (CRVO) and in Phase 2 Study in Diabetic Macular Edema (DME)
3. Regeneron Schedules December 20, 2010 Teleconference and Webcast to Discuss Results of VEGF Trap-Eye Phase 3 Study in Central Retinal Vein Occlusion (CRVO) and Phase 2 Study in Diabetic Macular Edema (DME)
4. An ITG Majestic Market Research Study Indicates a Bright Future for Gilenya, Despite Concerns About Its Safety
5. Beaumont Hospital Launches Study of Single-Dose Radiation Treatment for Prostate Cancer
6. ADVENTRX Requests Meeting with FDA to Discuss ANX-514 Study
7. Robotic Prostatectomy Expert Dr. David Samadi, MD Discusses Prostate Cancer Staging and Prostate Cancer Recurrence Study
8. Study Shows BSGI/MBI Contributes Significantly to Patient Management with Its Ability to Detect Breast Cancer in Difficult to Diagnose Patients
9. ISTA Pharmaceuticals Initiates Phase 2 Clinical Study of Bepotastine Besilate Nasal Spray for the Treatment of Symptoms Associated with Seasonal Allergic Rhinitis
10. New Clinical Study Presented at the American Association of Respiratory Care Finds Masimo Rainbow Acoustic Monitoring Accurate for Respiration Rate Assessment
11. Published Study Concludes: Vented Baby Bottles Protect Essential Nutrients in Breast Milk and Formula
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... OmniSeq, LLC today announced the addition ... SM Genomic Network.  Recently, OmniSeq officially spun ... announced it was making available a suite of ... to genomic diagnostics that provides actionable results to ... rapidly expanding, multidisciplinary cancer care center that is ...
(Date:8/3/2015)... 3, 2015  Sage Analytics ( www.sageanalytics.com ), the ... potency measurement systems, announced its sponsorship of the California ... A limited number of tickets are available for groups ... great cause while enjoying an open bar, buffet dinner ... San Francisco Bay at sunset. With the ...
(Date:8/3/2015)... 3, 2015 Ortho Clinical Diagnostics (OCD) today ... Chief Corporate Brand and Communications Officer, effective immediately. As ... Bouryal will lead the company,s worldwide corporate brand and ... to an independent company by adding sites in countries ... Chief Executive Officer Dr. Martin Madaus . ...
Breaking Medicine Technology:OmniSeq Adds Wilmot Cancer Institute to its Collaboration-Based Treatment Network 2OmniSeq Adds Wilmot Cancer Institute to its Collaboration-Based Treatment Network 3Sage Analytics Sponsors California Cannabis Industry Association Bay Area Cruise FUNdraiser 2Ortho Clinical Diagnostics Appoints Kristie Bouryal Chief Corporate Brand and Communications Officer 2
... , , PHILADELPHIA, Dec. 23 ... USP) Co-Pay Assistance Program, an initiative designed to save patients money ... allows many patients to pay no more than $25 for a ... prescription. Colcrys is indicated for the prevention and treatment of gout ...
... Group, Inc. (OTC Bulletin Board: MDXG.OB) announced today that it ... In April 2009, The Food and Drug Administration cleared the ... anterior vertebral surgeries. The Vaso Shield is a permanent ... applications, as well as a proprietary manufacturing process. ...
Cached Medicine Technology:URL Pharma Launches Co-Pay Assistance Program for Colcrys(R) 2URL Pharma Launches Co-Pay Assistance Program for Colcrys(R) 3URL Pharma Launches Co-Pay Assistance Program for Colcrys(R) 4MiMedx Group Announces Launch of its Paradis Vaso Shield(TM) Device 2MiMedx Group Announces Launch of its Paradis Vaso Shield(TM) Device 3
(Date:8/3/2015)... ... August 03, 2015 , ... They know every second counts. And when it ... offers some of the best care in the nation. For the past two months, ... average blood clot removal time in the country. During the months of June and ...
(Date:8/3/2015)... ... , ... Bayer has agreed to pay $56.9 million to set up a ... to have suffered an arterial blood clot including stroke and heart attack. The litigation ... has been ongoing for well-over five years. In 2009, lawsuits filed against Bayer involving ...
(Date:8/3/2015)... ... 03, 2015 , ... Kantor & Kantor, LLP announced today ... client Rebecca Hamsher, deciding that in accordance with ERISA ( Employee Retirement Income ... treatment for bulimia, depression and other mental health problems. , According to the ...
(Date:8/3/2015)... ... August 03, 2015 , ... ... MarketingProfs Bright Bulb B2B Awards. , The MarketingProfs Bright Bulb B2B Awards celebrate ... BESLER Consulting's campaign for the launch of their Readmissions Analytics product was selected ...
(Date:8/3/2015)... ... August 03, 2015 , ... Pitt Researchers to Monitor ... of Pittsburgh School of Medicine are leading a five-year, $5 million initiative to ... , A cooperative agreement awarded by the U.S. Agency for International Development ...
Breaking Medicine News(10 mins):Health News:Providence St. Vincent Stroke Care Recognized Among Best in the Country 2Health News:Providence St. Vincent Stroke Care Recognized Among Best in the Country 3Health News:Bayer Agrees To Settle Yaz Aterial Blood Clot Lawsuits 2Health News:Kantor & Kantor Announces North Cypress Medical Center Must Reimburse Benefits for Mental Health Treatment 2Health News:Kantor & Kantor Announces North Cypress Medical Center Must Reimburse Benefits for Mental Health Treatment 3Health News:$5M Effort to Guide Use of HIV Prevention Meds in Africa 2Health News:$5M Effort to Guide Use of HIV Prevention Meds in Africa 3Health News:$5M Effort to Guide Use of HIV Prevention Meds in Africa 4
... 6 Mergent, Inc., administrator for the,Healthshares(TM) Indexes, ... Exchange Traded Funds, today announced the following,changes with ... May 9, 2008:,Masimo Corporation (Nasdaq: MASI ) ... in the HealthShares(TM) Composite Index, Quest,Diagnostics Inc (NYSE: ...
... Traffic Reached Record Levels of 51.9 Million Unique Monthly Users and ... ... Health Corp. (Nasdaq:,WBMD) today announced financial results for the three months ... quarter, as,WebMD continued to consolidate its position as the leading source ...
... the annual shareholders,meeting of Sigma-Aldrich Corporation (Nasdaq: SIAL ... re-elected: David R. Harvey, W. Lee,McCollum, Jai P. Nagarkatti, ... R. G. Sear, D. Dean Spatz and Barrett A. ... of Medtronic, Inc., was,elected to her first term as ...
... deals another blow to homocysteine theory , , TUESDAY, May ... supplements aimed at reducing blood levels of the amino ... and stroke, a long-term study found. , It,s the ... lowering homocysteine levels could reduce the incidence of cardiovascular ...
... Healthcare Workers Demonstrate to Protect Their Voice & Vote ... The battle,over the direction of the Service Employees International ... of hearings was held to,determine the fate of more ... Workers -- West (UHW). UHW represents 150,000,caregivers in hospitals, ...
... Epitomics, Inc. announced,today that its Hangzhou subsidiary has ... of its novel line of rabbit monoclonal,antibodies. "This ... quality management and ultimately the finest quality,antibodies available ... Yu,President and CEO of Epitomics, Inc., "ISO ...
Cached Medicine News:Health News:Mergent, Inc. Announces Changes to the HealthShares(TM) Composite, Enabling Technologies, Autoimmune-Inflammation, Cancer, Cardiology and Neuroscience Indexes 2Health News:Mergent, Inc. Announces Changes to the HealthShares(TM) Composite, Enabling Technologies, Autoimmune-Inflammation, Cancer, Cardiology and Neuroscience Indexes 3Health News:Mergent, Inc. Announces Changes to the HealthShares(TM) Composite, Enabling Technologies, Autoimmune-Inflammation, Cancer, Cardiology and Neuroscience Indexes 4Health News:WebMD Announces First Quarter Financial Results 2Health News:WebMD Announces First Quarter Financial Results 3Health News:WebMD Announces First Quarter Financial Results 4Health News:WebMD Announces First Quarter Financial Results 5Health News:WebMD Announces First Quarter Financial Results 6Health News:WebMD Announces First Quarter Financial Results 7Health News:WebMD Announces First Quarter Financial Results 8Health News:WebMD Announces First Quarter Financial Results 9Health News:WebMD Announces First Quarter Financial Results 10Health News:WebMD Announces First Quarter Financial Results 11Health News:WebMD Announces First Quarter Financial Results 12Health News:WebMD Announces First Quarter Financial Results 13Health News:WebMD Announces First Quarter Financial Results 14Health News:WebMD Announces First Quarter Financial Results 15Health News:WebMD Announces First Quarter Financial Results 16Health News:WebMD Announces First Quarter Financial Results 17Health News:WebMD Announces First Quarter Financial Results 18Health News:WebMD Announces First Quarter Financial Results 19Health News:WebMD Announces First Quarter Financial Results 20Health News:Sigma-Aldrich Shareholders Elect Directors and Ratify Auditor; Directors Declare Quarterly Dividend 2Health News:Folic Acid Doesn't Help the Heart 2Health News:SEIU Retaliates Against California Caregivers & Democratic Reform Movement 2Health News:Epitomics receives ISO 9001 certification for the production of Rabbit Monoclonal Antibodies. 2
Instrument necessary for insertion of Ritleng Bicanaliculus systems and of Self-Threading Monoka systems....
... This unique system uses prolene as thread-guide ... intubation. The hollow Ritleng Probe is inserted ... prolene thread-guide is fed through it. The ... thread to pull the silicone tubing in ...
... system uses prolene as thread-guide reducing time ... hollow Ritleng Probe is inserted into the ... is fed through it. The probe is ... pull the silicone tubing in place. Newly ...
For Canalicular Stenosis in Infants. Medical grade silicone. Note: Can also be used in DCR because of its high flexibility. Probe entirely embedded in silicone tubing (non-traumatic). Box of 3, steri...
Medicine Products: